51 related articles for article (PubMed ID: 29121822)
1. Investigation of efficacy of treatment in spinal cord injury: Erythropoietin versus methylprednisolone.
Ozkunt O; Sariyilmaz K; Gemalmaz HC; Gürgen SG; Yener U; Dikici F
J Orthop Surg (Hong Kong); 2017; 25(3):2309499017739481. PubMed ID: 29121822
[TBL] [Abstract][Full Text] [Related]
2. The combination treatment of methylprednisolone and growth factor-rich serum ameliorates the structural and functional changes after spinal cord injury in rat.
Mousavi SR; Farrokhi MR; Ghaffari MK; Karimi F; Keshavarz S; Dehghanian AR; Naseh M
Spinal Cord; 2024 Jan; 62(1):17-25. PubMed ID: 38001173
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the effect of intrathecal GM1 in 24, 48, and 72 hours after acute spinal cord injury in rats.
Jorge DMF; Marcon RM; Cristante AF; Filho TEPB; Dos Santos GB
Clinics (Sao Paulo); 2023; 78():100228. PubMed ID: 37418797
[TBL] [Abstract][Full Text] [Related]
4. Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury.
Gorio A; Madaschi L; Di Stefano B; Carelli S; Di Giulio AM; De Biasi S; Coleman T; Cerami A; Brines M
Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16379-84. PubMed ID: 16260722
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effect of Mongolian drug Naru-3 on traumatic spinal cord injury and its mechanism of action.
Baiyila B; He B; He G; Long T
J Int Med Res; 2018 Jun; 46(6):2346-2358. PubMed ID: 29614905
[TBL] [Abstract][Full Text] [Related]
6. A novel technique to develop thoracic spinal laminectomy and a methodology to assess the functionality and welfare of the contusion spinal cord injury (SCI) rat model.
V S H; Krishnan LK; Abelson KSP
PLoS One; 2019; 14(7):e0219001. PubMed ID: 31265469
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral-Induced Spinal Cord Gliomas in Rat Model.
Nagarajan PP; Tora MS; Neill SG; Federici T; Texakalidis P; Donsante A; Canoll P; Lei K; Boulis NM
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884748
[TBL] [Abstract][Full Text] [Related]
8. Preparation and Evaluation of Recombinant Human Erythropoietin Loaded Tween 80-Albumin Nanoparticle for Traumatic Brain Injury Treatment.
Xue Y; Ding J; Liu Y; Pan Y; Zhao P; Ren Z; Xu J; Ye L; Xu Y
Int J Nanomedicine; 2020; 15():8495-8506. PubMed ID: 33154639
[TBL] [Abstract][Full Text] [Related]
9. Effects of Electrospun Nanofibers on Motor Function Recovery After Spinal Cord Injury: A Systematic Review and Meta-Analysis.
Haeri Moghaddam N; Hashamdar S; Hamblin MR; Ramezani F
World Neurosurg; 2024 Jan; 181():96-106. PubMed ID: 37852475
[TBL] [Abstract][Full Text] [Related]
10. An updated systematic review of neuroprotective agents in the treatment of spinal cord injury.
Serag I; Abouzid M; Elmoghazy A; Sarhan K; Alsaad SA; Mohamed RG
Neurosurg Rev; 2024 Mar; 47(1):132. PubMed ID: 38546884
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the neuroprotective effects of ozone in an experimental spine injury model.
Gürkan G; Sayin M; Kizmazoglu C; Erdogan MA; Yigitturk G; Erbak Yilmaz H; Uzunoglu I; Kaya I; Yuceer N
J Neurosurg Spine; 2020 May; 33(3):406-414. PubMed ID: 32413852
[TBL] [Abstract][Full Text] [Related]
12. Letter to the Editor. Methylprednisolone following acute traumatic spinal cord injury.
Nash MS; Boddu JV; Green BA
J Neurosurg Spine; 2023 Sep; 39(6):851-852. PubMed ID: 37657094
[No Abstract] [Full Text] [Related]
13. Grb2 Expression in Acute Spinal Cord Injury After Methylprednisolone Intrathecal Injection in Rats.
Zhou Y; Sun G; Li C; Bai X
Int J Spine Surg; 2023 Oct; 17(5):678-683. PubMed ID: 37884335
[TBL] [Abstract][Full Text] [Related]
14. Retracted: Microarray and Bioinformatics Analysis of Differential Gene and lncRNA Expression during Erythropoietin Treatment of Acute Spinal Cord Injury in Rats.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9843413. PubMed ID: 38094373
[TBL] [Abstract][Full Text] [Related]
15. Neurological recovery and antioxidant effect of erythropoietin for spinal cord injury: A systematic review and meta-analysis.
Zhang YY; Yao M; Zhu K; Xue RR; Xu JH; Cui XJ; Mo W
Front Neurol; 2022; 13():925696. PubMed ID: 35928137
[TBL] [Abstract][Full Text] [Related]
16. Effects of ganglioside GM1 and erythropoietin on spinal cord injury in mice: Functional and immunohistochemical assessments.
Torelli AG; Cristante AF; de Barros-Filho TEP; Dos Santos GB; Morena BC; Correia FF; Paschon V
Clinics (Sao Paulo); 2022; 77():100006. PubMed ID: 35193085
[TBL] [Abstract][Full Text] [Related]
17. Perspectives in the Cell-Based Therapies of Various Aspects of the Spinal Cord Injury-Associated Pathologies: Lessons from the Animal Models.
Zawadzka M; Kwaśniewska A; Miazga K; Sławińska U
Cells; 2021 Nov; 10(11):. PubMed ID: 34831217
[TBL] [Abstract][Full Text] [Related]
18. Facile fabrication of an erythropoietin-alginate/chitosan hydrogel and evaluation of its local therapeutic effects on spinal cord injury in rats.
Gholami M; Gilanpour H; Sadeghinezhad J; Asghari A
Daru; 2021 Dec; 29(2):255-265. PubMed ID: 34491566
[TBL] [Abstract][Full Text] [Related]
19. Standardization of an experimental model of intradural injection after spinal cord injury in rats.
Letaif OB; Tavares-Júnior MCM; Santos GBD; Ferreira RJR; Marcon RM; Cristante AF; Barros-Filho TEP
Clinics (Sao Paulo); 2021; 76():e2740. PubMed ID: 33787659
[TBL] [Abstract][Full Text] [Related]
20. Human Brain-Derived Neurotrophic Factor Gene-Modified Bone Marrow Mesenchymal Stem Cells Combined With Erythropoietin Can Improve Acute Spinal Cord Injury.
Li Y; Wang H; Ding X; Shen J; Zhou H; Jiang D; Jin C; Li K
Dose Response; 2020; 18(1):1559325820910930. PubMed ID: 32284696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]